McFarlane Neil F.insider trades
In SEC Form 4 filings, McFarlane Neil F. is listed as President and CEO of Zevra Therapeutics, Inc. (ZVRA). In the last 90 days, McFarlane Neil F. sold $224.9K of Zevra Therapeutics, Inc. (ZVRA) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ZVRAZevra Therapeutics, Inc. | President and CEO | 3 | Oct 13 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-13
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ZVRAZevra Therapeutics, Inc. | Oct 12 | Oct 13 | S | 20,000 | $11.25 | Sale −$224,948 | 417,225 | Yes | Form 4 |
| ZVRAZevra Therapeutics, Inc. | Oct 10 | Oct 13 | M | 50,000 | not reported | not reported | 437,225 | Yes | Form 4 |
| ZVRAZevra Therapeutics, Inc. | Oct 10 | Oct 13 | M · derivative | 50,000 | $0.00 | $0 | 50,000 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.